3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Multiple Myeloma
154
Lymphoma
78
Lymphoma, Non-Hodgkin
62
Neoplasms, Plasma Cell
54
Leukemia
52
Leukemia, Myeloid, Acute
49
Hodgkin Disease
48
Precursor Cell Lymphoblastic Leukemia-Lymphoma
45
Leukemia, Lymphocytic, Chronic, B-Cell
45
Myelodysplastic Syndromes
42
Lymphoma, Large B-Cell, Diffuse
41
Lymphoma, Follicular
40
Lymphoma, Mantle-Cell
38
Lymphoma, Large-Cell, Immunoblastic
29
Neuroblastoma
27
Burkitt Lymphoma
27
Lymphoma, B-Cell, Marginal Zone
26
Recurrence
22
Immunoglobulin Light-chain Amyloidosis
22
Myeloproliferative Disorders
18
Leukemia, Myeloid, Accelerated Phase
16
Hematologic Neoplasms
16
Congenital Abnormalities
16
Leukemia, Myeloid, Chronic-Phase
14
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
14
Graft vs Host Disease
14
Dendritic Cell Sarcoma, Interdigitating
14
Waldenstrom Macroglobulinemia
13
Leukemia, Myelomonocytic, Chronic
13
Blast Crisis
13
Interventions
Temozolomide
7
Carboplatin
4
Vincristine
3
Surveys and Questionnaires
3
Radiotherapy
3
Magnetic Resonance Imaging
3
Bevacizumab
3
Vorinostat
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Etoposide
2
Disulfides
2
veliparib
1
tozuleristide
1
romidepsin
1
lonafarnib
1
ispinesib
1
etoposide phosphate
1
emvododstat
1
cediranib
1
Valproic Acid
1
Thiotepa
1
Standard of Care
1
Saline Solution
1
Radiosurgery
1
Radiation
1
Pregabalin
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Spinal Cord Neoplasms
×
Melphalan
×
Clear all
NCT01637766
2020-08-03
SIAC
Weill Medical College of Cornell University
Phase 1
Completed
12 enrolled